Cipla schedules board meeting

Net Sales are expected to decrease by 4.43 percent Q-o-Q (down 4.78 percent Y-o-Y) to Rs 3332.5 crore, according to KR Choksey. Cipla to report net profit at 199.6 crore down 427.75% quarter-on-quarter.

ICICI Bank | Wipro | Mahindra and Mahindra | Cadila Healthcare | Gruh Finance | Cipla | Ujaas Energy | Karnataka Bank | Indraprastha Gas | GTL Infra | Inox Wind | GMR Infra | Shreyas Shipping | Alembic | Alkem Labs | Capital First | WPIL and Lypsa Gems are ...

Lupin, Tata Power, SBI, BPCL, Bajaj Auto, Aurobindo Pharma and Sun Pharma were early gainers while Bharti Airtel lost 0.8 percent after yesterday#39;s 5 percent rally.

Cipla, Glenmark Pharma to catch up by FY21-22

A huge pay gap between CEOs and other employees at Indian companies has come to the fore, with the biggest listed blue-chip firms doling out to their top executives salary packages of up to 1,200-times of their median employee remunerations. An analysis of ...

BSE sensex is up in the green by 0.45% or 145.24 points to 31858.44 at 10:38 AM, while NSE Nifty is up by 48.80 points or 0.50% at 9875.95. Hindalco, Tata Steel, Reliance Communications, Bharti Airtel and Cipla Ltd showed good growth numbers in the ...

Posted by Equitymaster Global financial markets ended the week on a positive note with an upward boost from Brazil, Hong Kong and Indian share markets, which were up 5%, 4.1% and 2.1% respectively. While the US markets ended the week marginally lower by 0.2%, ...

After four consecutive sessions of gains, the Indian equity markets closed on a nominally lower note on Friday as investors booked profit -- the key indices, however, touched fresh intra-day highs. The wider Nifty of the National Stock Exchange (NSE) breached ...

Pharma stocks are doing well on the Nifty50 on Friday. Lupin Pharma, Aurobindo pharma, Dr Reddy, and Cipla have all remained in the green today. Lupin Pharma traded to a high of 1137 after opening at 1081.30. The scrip is currently up 3.8% at Rs 1122.40.